APRICUS BIOSCIENCES, INC. Underwriting Agreements
10 Contracts & Agreements
- Underwriting Agreement, dated as of November 28, 2023, by and between Seelos Therapeutics, Inc. and Titan Partners Group, LLC (Filed With SEC on November 30, 2023)
- Underwriting Agreement, dated as of May 20, 2021, by and between Seelos Therapeutics, Inc. and Guggenheim Securities, LLC (Filed With SEC on May 21, 2021)
- Underwriting Agreement, dated as of January 25, 2021, by and between Seelos Therapeutics, Inc. and BTIG, LLC (Filed With SEC on January 26, 2021)
- Underwriting Agreement, dated as of March 11, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein (Filed With SEC on March 12, 2020)
- Underwriting Agreement, dated as of February 10, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein (Filed With SEC on February 11, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 30, 2020)
- ____________ SHARES OF COMMON STOCK AND _____________ WARRANTS OF APRICUS BIOSCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 20, 2017)
- ____________ SHARES OF COMMON STOCK AND _____________ WARRANTS OF APRICUS BIOSCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 17, 2017)
- 6,000,000 Shares of Common Stock, par value$0.001 Warrants to Purchase 3,000,000 Shares of Common Stock and 900,000 Over-Allotment Shares Over-Allotment Warrants to Purchase... (Filed With SEC on May 24, 2013)
- 4,938,272 Shares of Common Stock, par value $0.001 Warrants to Purchase 2,469,136 Shares of Common Stock and 740,740 Over-Allotment Shares Over-Allotment Warrants to Purchase... (Filed With SEC on February 13, 2012)
